* Investors will look for clues regarding the timing of an interest
rate hike when Yellen delivers a speech on inflation, a topic that
is key to liftoff and one that has divided policymakers. The speech
is at 5 p.m. ET (2100 GMT).
* U.S. stocks closed slightly lower on Wednesday, as weak factory
data from China and the United States led to a selloff in materials
and industrial stocks.
* Seeking to warm bilateral ties and project a sunny climate for
U.S. business, Chinese President Xi Jinping vowed on Wednesday to
cut restrictions on foreign investment.
* The U.S. equity market has been skittish since last Thursday when
the Fed held off from raising rates, as was expected by some. The
S&P 500 has fallen 2.8 percent since then.
* The market has already had a volatile month as concerns regarding
a slowing Chinese economy and uncertainty regarding the timing of a
Fed rate hike have caused sharp swings.
![](http://archives.lincolndailynews.com/2015/Sep/24/images/ads/current/st_clara_sda_daily_fallfest_2015.png)
* U.S. economic data expected on Thursday includes weekly jobless
claims, which is expected to have risen by 7,000 to 271,000. The
data is due at 8:30 a.m.
* Also at 8:30 a.m., durable goods data for August is expected to
show orders fell 2 percent, after rising 2.2 percent in July.
* A report on new single-family home sales at 10:00 a.m. is expected
to show a 1.6 percent increase in August, slower than a 5.4 percent
jump in July.
* Companies expected to report quarterly earnings on Thursday
include Accenture and KB Home before the bell. Nike and Bed Bath &
Beyond are schedule to report after the market closes.
[to top of second column] |
![](http://archives.lincolndailynews.com/2015/Sep/24/images/ads/current/revolving-ad_graue_sep_2015.gif)
* S&P 500 earnings are projected to decline 3.9 percent in the third
quarter from a year ago, Thomson Reuters data shows.
* Shares of Caterpillar fell 2.4 percent to $68.50 after Axiom
Capital started coverage with a "sell" rating, according to
Streetinsider.com.
* Conatus Pharmaceuticals jumped 35.9 percent to $7.80 after its
experimental liver cirrhosis drug met mid-stage study goals.
Futures snapshot at 7:14 a.m. ET:
* S&P 500 e-minis were down 15.5 points, or 0.8 percent, with
230,212 contracts traded.
* Nasdaq 100 e-minis were down 43 points, or 1.01 percent, on volume
of 46,804 contracts.
* Dow e-minis were down 138 points, or 0.85 percent, with 39,146
contracts changing hands.
(Reporting by Abhiram Nandakumar in Bengaluru; Editing by Savio
D'Souza)
[© 2015 Thomson Reuters. All rights
reserved.] Copyright 2015 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
![](http://archives.lincolndailynews.com/2015/Sep/24/images/ads/current/business_directory_filler.png)
![](http://archives.lincolndailynews.com/2015/Sep/24/images/ads/current/ccaonline_sda050208.png) |